Drug intelligence / Profile preview

chlorobutanol

Development stage
Phase 4
Modality
Small Molecules
Administration
Intravenous, Intramuscular, Subcutaneous, Ophthalmic, Topical
01

Overview

Chlorobutanol is a colorless to white crystalline compound with a camphoraceous odor and taste. It is an alcohol-based preservative widely used in pharmaceutical solutions—especially injectables and ophthalmic preparations—due to its antibacterial and antifungal properties[5][3][7]. Chlorobutanol also exhibits sedative-hypnotic effects and weak local anesthetic actions similar to chloral hydrate[5][4]. Its mechanism of action includes disruption of cell membrane lipids leading to increased permeability and cell lysis; it can inhibit voltage-gated sodium channels (Nav 1.2) in neurons at concentrations lower than those used for preservation[8][4]. Additionally, it inhibits hERG potassium channels at millimolar concentrations[6], which may contribute to its negative inotropic effects on cardiac tissue. Chlorobutanol is not commonly used as a systemic sedative due to its long terminal half-life (about 37 days), which leads to accumulation with repeated dosing[2]. It was first synthesized by Conrad Willgerodt in 1881.

Other names
trichloro-2-methyl-2-propanoltrichloro2-methyl-2-propanoltrichloro 2-methyl-2-propanol1,1,1-trichloro-2-methylpropan-2-ol1,1,1-trichloro-tert-butyl alcohol2,2,2-trichloro-1,1-dimethylethanol2-propanol 1,1,1-trichloro-2-methyl-trichlorisobutylalcohol
02

Targets

KCNH2 (Voltage-gated potassium channel subfamily H member 2)SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)

Beyond the preview

Go deeper on chlorobutanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorobutanol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call